Skip to main content
Clinical Trials/ACTRN12618001717246
ACTRN12618001717246
Completed
未知

The effectiveness of a novel multidisciplinary therapy program on clinical and biological measures of disease progression in individuals with Huntington's disease.

Edith Cowan University0 sites40 target enrollmentOctober 17, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Huntington's Disease
Sponsor
Edith Cowan University
Enrollment
40
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 17, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for premanifest HD individuals were a cytosine\-adenine\-guanine (CAG) repeat length \> 39 and a diagnostic confidence score \< 4 on the Unified Huntington’s Disease Rating Scale Total Motor Score (UHDRS\-TMS) (Reilmann et al., 2014\).

Exclusion Criteria

  • Exclusion criteria were the presence of known musculoskeletal, metabolic, endocrine or cardiovascular disorders, recent or long\-standing substance abuse, shift work other neurological conditions.

Outcomes

Primary Outcomes

Not specified

Similar Trials